Cardiospondylocarpofacial syndrome

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:3238OMIM:157800Q87.8
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Cardiospondylocarpofacial syndrome (CSCF syndrome), also known as Sotos-like syndrome or previously as cardio-spondylo-carpo-facial syndrome, is an extremely rare genetic disorder characterized by a combination of cardiac, vertebral, carpal (wrist bone), and facial abnormalities. The condition is caused by mutations in the MAP3K7 gene, which encodes a protein involved in important signaling pathways during development. Key clinical features include congenital heart defects (such as atrial and ventricular septal defects, patent ductus arteriosus), vertebral segmentation anomalies, carpal and tarsal bone synostosis (fusion of wrist and ankle bones), short stature, and distinctive facial features. The facial characteristics may include a broad forehead, hypertelorism (widely spaced eyes), short nose with a broad nasal bridge, and micrognathia (small jaw). Additional features can include hearing loss, dental anomalies, and mild intellectual disability in some cases. The syndrome affects multiple body systems including the cardiovascular, skeletal, and craniofacial systems. Skeletal manifestations may also include scoliosis, fused cervical vertebrae, and brachydactyly (short fingers). The condition is present from birth, with many features identifiable in the neonatal or early infantile period. There is no specific cure for cardiospondylocarpofacial syndrome, and management is supportive and symptom-based. Treatment typically involves cardiac surgery or monitoring for heart defects, orthopedic management for skeletal abnormalities, and developmental support as needed. Regular follow-up with a multidisciplinary team including cardiologists, orthopedic specialists, and geneticists is recommended.

Also known as:

Clinical phenotype terms— hover any for plain English:

Tooth malpositionHP:0000692Failure of eruption of permanent teethHP:0006352
Inheritance

Autosomal dominant

Passed on from just one parent; each child has about a 50% chance of inheriting it

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Cardiospondylocarpofacial syndrome.

View clinical trials →

No actively recruiting trials found for Cardiospondylocarpofacial syndrome at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Cardiospondylocarpofacial syndrome community →

No specialists are currently listed for Cardiospondylocarpofacial syndrome.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Cardiospondylocarpofacial syndrome.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Cardiospondylocarpofacial syndromeForum →

No community posts yet. Be the first to share your experience with Cardiospondylocarpofacial syndrome.

Start the conversation →

Latest news about Cardiospondylocarpofacial syndrome

No recent news articles for Cardiospondylocarpofacial syndrome.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Cardiospondylocarpofacial syndrome

What is Cardiospondylocarpofacial syndrome?

Cardiospondylocarpofacial syndrome (CSCF syndrome), also known as Sotos-like syndrome or previously as cardio-spondylo-carpo-facial syndrome, is an extremely rare genetic disorder characterized by a combination of cardiac, vertebral, carpal (wrist bone), and facial abnormalities. The condition is caused by mutations in the MAP3K7 gene, which encodes a protein involved in important signaling pathways during development. Key clinical features include congenital heart defects (such as atrial and ventricular septal defects, patent ductus arteriosus), vertebral segmentation anomalies, carpal and ta

How is Cardiospondylocarpofacial syndrome inherited?

Cardiospondylocarpofacial syndrome follows a autosomal dominant inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Cardiospondylocarpofacial syndrome typically begin?

Typical onset of Cardiospondylocarpofacial syndrome is neonatal. Age of onset can vary across affected individuals.